EQL Pharma AB (publ) (STO: EQL)
Sweden
· Delayed Price · Currency is SEK 71.60
+1.20 (1.70%)
At close: Jan 17, 2025
EQL Pharma AB Revenue
EQL Pharma AB had revenue of 85.25M SEK in the quarter ending September 30, 2024, with 42.99% growth. This brings the company's revenue in the last twelve months to 316.38M, up 23.42% year-over-year. In the fiscal year ending March 31, 2024, EQL Pharma AB had annual revenue of 264.17M with 1.64% growth.
Revenue (ttm)
316.38M
Revenue Growth
+23.42%
P/S Ratio
7.02
Revenue / Employee
15.82M
Employees
21
Market Cap
2.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 264.17M | 4.26M | 1.64% |
| Mar 31, 2023 | 259.91M | -149.84M | -36.57% |
| Mar 31, 2022 | 409.75M | 230.61M | 128.73% |
| Mar 31, 2021 | 179.14M | 107.11M | 148.70% |
| Mar 31, 2020 | 72.03M | 22.28M | 44.77% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 265.08B |
| Atlas Copco AB | 175.74B |
| AB Volvo | 536.90B |
| EQT AB | 24.99B |
| ASSA ABLOY AB | 147.56B |
| Skandinaviska Enskilda Banken AB | 80.87B |
| Telefonaktiebolaget LM Ericsson | 246.85B |
| Hexagon AB | 60.95B |